Renal acidifying ability in subjects with recurrent stone formation.

Area of Science:

• Nephrology
• Urology
• Endocrinology

Background:

• Calcium stones are a common condition.
• Renal tubular acidosis (RTA) can contribute to stone formation.
• The role of parathyroid hormone (PTH) in RTA and stone disease requires further elucidation.

Purpose of the Study:

• To determine the incidence of urine acidification defects in men with calcium stones.
• To investigate the relationship between these defects and parathyroid function.
• To identify potential therapeutic implications for managing calcium stone disease.

Main Methods:

• 120 male patients with calcium stones underwent an acute oral ammonium chloride loading test.
• Circulating immunoreactive parathyroid hormone (iPTH) levels were measured.
• Patients were stratified into two groups based on iPTH levels (≤60 mulEq/ml vs. >60 mulEq/ml).
• Urine pH was monitored to assess acidification capacity.

Main Results:

• The overall incidence of abnormal urine acidification was 6%.
• All patients with abnormal acidification presented with incomplete renal tubular acidosis.
• No significant difference in minimal urine pH was observed between patients with normal acidification, irrespective of iPTH levels.
• Abnormal acidification occurred in both low and high iPTH groups (3/46 vs. 5/74).

Conclusions:

• A 6% incidence of incomplete renal tubular acidosis was identified in men with calcium stones.
• Parathyroid hormone levels do not appear to influence the urine acidification capacity in this cohort.
• These findings suggest that impaired urine acidification is an independent factor in calcium stone formation and has therapeutic relevance.